PubMed:33040469
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 23-30 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T2 | 233-240 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T3 | 532-539 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T4 | 627-634 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T5 | 667-674 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T6 | 810-817 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T7 | 860-867 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 17-22 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T2 | 23-30 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T3 | 227-232 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T4 | 233-240 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T5 | 526-531 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T6 | 532-539 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T7 | 621-626 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T8 | 627-634 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T9 | 661-666 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T10 | 667-674 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T11 | 804-809 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T12 | 810-817 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T13 | 854-859 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T14 | 860-867 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 17-22 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T2 | 227-232 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T3 | 526-531 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T4 | 621-626 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T5 | 661-666 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T6 | 804-809 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T7 | 854-859 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 125-133 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 163-171 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T3 | 368-376 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T4 | 405-429 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 431-439 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 511-519 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T7 | 591-599 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 678-702 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 704-712 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 740-748 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T11 | 871-879 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 906-914 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T13 | 966-974 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T14 | 1081-1089 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 17-22 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T2 | 17-22 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T3 | 173-174 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T4 | 227-232 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T5 | 227-232 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T6 | 269-270 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 526-531 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T8 | 526-531 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T9 | 621-626 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T10 | 621-626 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T11 | 661-666 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T12 | 661-666 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T13 | 793-794 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T14 | 804-809 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T15 | 804-809 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T16 | 820-821 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T17 | 854-859 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T18 | 854-859 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 23-30 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T3 | 233-240 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T5 | 532-539 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T7 | 627-634 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T9 | 667-674 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T11 | 810-817 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T13 | 860-867 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 23-30 | Chemical | denotes | glucose | MESH:D005947 |
5 | 125-133 | Disease | denotes | COVID-19 | MESH:C000657245 |
6 | 137-145 | Species | denotes | patients | Tax:9606 |
7 | 163-171 | Disease | denotes | diabetes | MESH:D003920 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-172 | Sentence | denotes | Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: |
T2 | 173-207 | Sentence | denotes | A multicenter observational study. |
T3 | 208-377 | Sentence | denotes | Highlights Fasting blood glucose < 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. |
T4 | 378-520 | Sentence | denotes | Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. |
T5 | 521-600 | Sentence | denotes | Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. |
T6 | 601-749 | Sentence | denotes | Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. |
T7 | 750-915 | Sentence | denotes | This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. |
T8 | 916-1118 | Sentence | denotes | Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26). |